These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1485917)
21. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
22. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats. Thompson TA; Haag JD; Gould MN Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551 [TBL] [Abstract][Full Text] [Related]
23. Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Roberts-Thomson SJ; Snyderwine EG Mol Carcinog; 1997 Dec; 20(4):348-54. PubMed ID: 9433479 [TBL] [Abstract][Full Text] [Related]
24. Transforming c-Ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea. Miyamoto S; Sukumar S; Guzman RC; Osborn RC; Nandi S Mol Cell Biol; 1990 Apr; 10(4):1593-9. PubMed ID: 2181280 [TBL] [Abstract][Full Text] [Related]
25. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437 [TBL] [Abstract][Full Text] [Related]
26. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets. Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772 [TBL] [Abstract][Full Text] [Related]
28. Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions. Korkola JE; Archer MC Carcinogenesis; 1999 Feb; 20(2):221-7. PubMed ID: 10069457 [TBL] [Abstract][Full Text] [Related]
29. Hormone dependent and independent mammary tumor development form N-methyl-N-nitrosourea-treated rat mammary epithelial cell xenografts in the nude mouse: multiple pathways and H-ras activation. Hwang SI; Guzman RC; Swanson SM; Nandi S Cancer Lett; 1996 Mar; 101(1):123-34. PubMed ID: 8625275 [TBL] [Abstract][Full Text] [Related]
30. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556 [TBL] [Abstract][Full Text] [Related]
31. Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor. Chou YC; Guzman RC; Swanson SM; Yang J; Lui HM; Wu V; Nandi S Carcinogenesis; 1999 Apr; 20(4):677-84. PubMed ID: 10223199 [TBL] [Abstract][Full Text] [Related]
32. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086 [TBL] [Abstract][Full Text] [Related]
33. Activation of ras oncogenes preceding the onset of neoplasia. Kumar R; Sukumar S; Barbacid M Science; 1990 Jun; 248(4959):1101-4. PubMed ID: 2188364 [TBL] [Abstract][Full Text] [Related]
34. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland. Zhang R; Haag JD; Gould MN Cell Growth Differ; 1991 Jan; 2(1):1-6. PubMed ID: 2007094 [TBL] [Abstract][Full Text] [Related]
35. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas. Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956 [TBL] [Abstract][Full Text] [Related]
36. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Haag JD; Hsu LC; Newton MA; Gould MN Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073 [TBL] [Abstract][Full Text] [Related]
37. Systematic HRAS amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes. Aldaz CM; Gollahon LS; Chen A Cancer Res; 1993 Nov; 53(22):5339-44. PubMed ID: 8221670 [TBL] [Abstract][Full Text] [Related]
38. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors. Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630 [TBL] [Abstract][Full Text] [Related]
39. Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782 [TBL] [Abstract][Full Text] [Related]
40. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]